Meet the Founder
Marcel V. Alavi, Ph.D.
Marcel founded 712 North in 2016 to develop therapies for fatal aging-related diseases by targeting mitochondrial inner membrane proteases. Before this, Marcel held postdoctoral appointments at the University of California, San Francisco (UCSF) and Johannes-Gutenberg University Mainz, where his research focused on vascular basement membrane defects and intraflagellar transport proteins. Marcel's professional career began in 2010 when he earned his Ph.D. summa cum laude from Eberhard-Karls University Tübingen, studying a genetic eye disease caused by mitochondrial defects. A leading expert in organelle biology, Marcel is an inventor on four patents and has authored 27 peer-reviewed research articles.
712 North at the BIO Investor Forum 2019 in San Francisco, CA
Contact us
Interested in learning more or working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!